Clinical Trial Update: Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

View source ↗

Summary

This completed clinical trial collected data on routine clinical use of the Spectra Optia Apheresis System for white blood cell depletion in leukocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocytosis

Drugs mentioned

• Spectra Optia Apheresis System

Snippet

Sponsor: Terumo BCT | Conditions: Leukocytosis | Status: COMPLETED | Results posted: 2016-03-03